Shares of Solventum Corp. SOLV advanced 1.74% to $66.63 Thursday, on what proved to be an all-around positive trading session ...

M spin-off Solventum beat analysts' estimate for first-quarter profit on Thursday, helped by higher sales of its wound care, sterilization products.

Healthcare solutions provider Solventum (NYSE:SOLV) announced in Q1 CY2025, with sales up 2.7% year on year to $2.07 billion.

Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the 2025 BofA Securities Health ...

The health care company posted revenue of $2.07 billion in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $2 billion. Solventum expects full-year earnings in ...

SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency ...

Solventum Corp. closed 22.15% below its 52-week high of $85.92, which the company reached on February 26th.

With a market cap of $11.5 billion, Solventum Corporation (SOLV) is a U.S.-based healthcare company that was spun off from 3M ...

SOLVENTUM ($SOLV) is expected to release its quarterly earnings data on Thursday, May 8th after market close, per Finnhub. Analysts are expecting revenue of ...

7 analysts have shared their evaluations of Solventum (NYSE:SOLV) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ...

In this article, we are going to take a look at where Solventum Corporation (NYSE:SOLV) stands against other best new stocks to buy according to billionaires. International IPO activity during the ...